The Center for Psychedelic Psychotherapy and Trauma Research

The Center for Psychedelic Psychotherapy and Trauma Research is a research center located in New York, New York. It employs 7 individuals and generates revenue exceeding $10,000. The Center was established in September 2020 and is affiliated with the Icahn School of Medicine at Mount Sinai and the James J. Peters Department of Veterans Affairs Medical Center. The Center focuses on exploring the therapeutic potential of psychedelic compounds, including MDMA and psilocybin, for treating post-traumatic stress disorder (PTSD) and other trauma-related conditions. Its research centers on conducting rigorous clinical trials of existing and novel psychedelic-assisted psychotherapies for trauma survivors, employing cutting-edge scientific methods to understand their mechanisms of action. They also aim to provide education and training to therapists, medical residents, and trainees interested in working with these therapies. The Center is led by Dr. Rachel Yehuda, a prominent figure in trauma studies and a recognized expert in psychedelic-assisted therapy for trauma and PTSD. Dr. Yehuda's team has achieved a 65% success rate in curing PTSD in participants through three treatments, leading to FDA approval of their protocol in 2016 and the designation of psychedelic-assisted therapy as a breakthrough therapy for expedited development. For more information about the Center for Psychedelic Psychotherapy and Trauma Research, visit icahn.mssm.edu/research/center-psychedelic-psychotherapy-trauma-research.